decisionhealth Newsletters, Answer Books - 2009 Issue 3 (March)
Dialysis / Coverage and coding for EPO
Subscribe or sign in to view the full article.
Article Overview
This article explains the general Medicare context for coverage and coding of erythropoiesis-stimulating therapy in dialysis and non-dialysis patients with renal-related anemia. It points readers to the Medicare Claims Processing Manual sections that address billing and coding guidance for EPO and darbepoetin alfa, making it relevant for dialysis facilities, billing staff, and coding professionals working with ESRD claims.
Why This Topic Matters
These services are frequently tied to Medicare ESRD billing requirements, so understanding where the official guidance lives helps coders and billers locate the correct coverage and claims-processing instructions.
What You Will Learn
- The Medicare context for erythropoiesis-stimulating therapy in renal disease
- How the article frames coverage differences between dialysis and non-dialysis patients
- Where Medicare’s billing and coding guidance is referenced for ESRD-related anemia treatment
- The general relationship between the article and official CMS manual guidance
Who Should Read This
- Medical coders
- Dialysis billing staff
- Revenue cycle teams
- ESRD facility administrators
- Compliance staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com